FACT SHEET

Biotechnology Clusters
in Germany

ISSUE 2022/2023

Germany’s biotech industry is thriving. Revenues morethan tripled in 2021 compared to the previous record year
2020. The biotech sector workforce increased to 44,500(2020: 38.500) over the same period. Funding reached
EUR 2.4 billion – showing that the record figures of 2020
were not a one-off exception but part of a longer trend.
A major success factor continues to be the close cooperation
between biotech companies, research institutes, technology
parks, and their local communities – all effectively coordinated by Germany’s biotech cluster organizations. In 2021, thenumber of biotechnology companies in Germany increased
to over 774. Biotechnology companies generated a record
EUR 26.3 billion in revenue while spending EUR 3.8 billion on
research and development activities.
Germany’s excellent R&D environment and increased public
interest in innovative therapies during the Covid-19 pandemic
contributed to the exceptional revenue growth. Every year
companies participate in thousands of research projects withpartners from industry and research institutes – the resulting
scientific output supports Germany’s reputation as one of thebest ecosystems for biotechnology R&D worldwide.
The “BioRegions” are cluster initiatives for the advancementof modern biotechnology in Germany – ranging from local
infrastructure including technology parks to statewide organizations. Over the past three decades, these clusters havebecome some of the world’s leading R&D hubs. Each region isrun by a dedicated cluster management and facilitates collaboration between universities, R&D institutes and companies.
Around 30 BioRegions are active members of AK Bioregio“Council of German BioRegions,” whose goal is to advance theGerman biotechnology sector by coordinating and promoting
local activities. AK BioRegio advances the exchange between
regional initiatives and relays its expertise to politicaldecision-makers.

Germany’s Biotechnology
Industry in Numbers
EUR 26.3 bn revenue+279 percent compared to 201944,500 employees+16 percent compared to pre-Corona period

EUR 3.8 bn R&D spending+54 percent increase

774 companies
including 24 listed corporations

Biotech Companies in Germany
in EUR billion
Revenue

R&D expenditure
26.3

4.8
2019

6.9
1.82020

3.8

2.5
2021

Source: BMWK; Ernst & Young Biotechnologie-Report Deutschland 2021
BIO Deutschland

Local cluster

12 BioCon Valley

Kiel

7.5

Schleswig-Holstein

Regional cluster

3 BioLAGO

213State-level cluster

4 BioM

Mecklenburg
Western-Pomerania

Schwerin

Hamburg

5 BioPark Regensburg
6 BMD Life Sciences

22

Bremen12

Niedersachsen

15

BIO.NRW

7Berlin

8 BioValley

Hanover
Potsdam

Magdeburg

BIOPRO

9 BioRegio STERN

Brandenburg
North RhineWestphalia

16

Saxony-Anhalt

Düsseldorf

19
10

Thuringia
CologneHessen

1418

Dresden

12 HealthCapital

14 medways
15 BioRegioNFrankfurt11RhinelandPalatinate

11 CI313 Life Science NordSaxony

201710 biosaxony

16 Cluster Biotechnology Bavaria
17 House of Pharma & Healthcare

SaarlandSaarbrückenBavaria

237BadenWürttemberg

83Source: GTAI Cluster Survey 2022

924

18 InfectoGnostics

Nuremberg

2119 glyconetBB

520 PROXYDRUGS
21 Forum MedTech Pharma

41622 DiagnostikNet-BB

Munich

23 BioRN Network

For more information
please check our website.

24 BioPharmaCluster South Germany

Source: GTAI Cluster Survey 2022

Electronics/Photonics

Materials Science

Micro/Nanotechnology

Multi-application

Digital HealthSurgery(Bio)Medical Engineering

Lab and Analytics

Diagnostics/Imaging

Medical Technology

Synthetic Biology

Biomaterials

Personalized Medicine

Cell Therapy

Gene Therapy

Novel Therapy
Approaches

Respiratory Diseases

Age-related Conditions

Immunology

CNS/Neurology

Infectious Diseases

Oncology

Drug Discovery/
Development

Bioinformatics

Stem Cells

Protein Technology

Pharmaceutical Science

Cellular Biology

Germany's biotechnology clusters span the entire value
chain. This table helps to find the right partner in Germany: Find your area of interest to identify clusters thatconsider this field their focus of expertise.

partners, and providing educational training programs.
The map illustrates the location of the clusters. Thenumbers refer to the corresponding numbers in thetable on the right.

Molecular Medicine

Biotechnology clusters in Germany include local technology parks and accelerators as well as organizations
that operate on a regional or state level. Dedicatedcluster managements provide a range of services, suchas obtaining funding for joint R&D projects, matching
7.6

Fundamental Research

Biotechnology Clusters
by Research Area
MEDICAL

Biotechnology Clusters
in Germany

Biotechnology Clusters by Field of ActivityScience &TechnologyPark

Start-up
IncubatorCorporateMembershipBase

Events andNetworkingResearchInstitutes

Focus
Area

1BIO.NRW

2

BioCon Valley

Health services/healthy aging,
digital health3

BioLAGO

Diagnostics, pharma, MedTech,eHealth

4 BioM
5

Personalzed and digital healthinnovation

BioPark Regensburg

6 BMD Life Sciences
7BIOPRO

8 BioValley
9 BioRegio STERN
10 biosaxony
11 CI3
12 HealthCapital

13 Life Science Nord

Hygiene, infection & health,
digitalization & precision
medicine

14 medways
15 BioRegioN
16Cluster Biotechnology
Bavaria

Personalized and digital health

17House of Pharma &Healthcare

Pharma and healthcare education, dialogue and research

18 InfectoGnostics

Infectious diseases diagnostics
and research

19 glyconetBB
20 PROXYDRUGS

Targeted protein degradation

21 Forum MedTech Pharma
22 DiagnostikNet-BB

IVD and laboratory medicine

23 BioRN Network
24

BioPharmaCluster
South Germany

Source: GTAI Cluster Survey 2022

Virus-based therapeutics

Our Support for Your Business in Germany
Germany Trade & Invest (GTAI) is the foreign trade and inward
investment agency of the Federal Republic of Germany. We
advise and support foreign companies planning to expand
into the German market and assist German companies seeking to enter global markets.

All investment-related services are provided entirely freeof charge and all enquiries are treated with the utmost
confidentiality.

Investor Consulting
Our Investor Consulting division of specialist industry teams
provide international investors in all sectors with comprehensive consultancy services specific to each individual investment project. Services include:

Dr. Gregor Kemper
Biotechnology
Germany Trade & Invest
gregor.kemper@gtai.com

Contact· Market and industry reports· Market entry analysis· Business and tax law information· Funding and financing information

Imprint

Stay informed about Germany
Visit us online atwww.gtai.com	Follow the latest investmentnews on Twitter@gtai_com

Publisher: Germany Trade and Invest
Gesellschaft für Außenwirtschaft und Standortmarketing mbH
Friedrichstraße 60, 10117 Berlin, Germany
T +49 30 200 099 0, invest@gtai.com
Executive Board: Dr. Jürgen Friedrich, Chairman/CEO,
Dr. Robert Hermann, CEOEditor: William MacDougall, GTAI
Layout: Danielle Röbbenack, GTAI
Print: Kern GmbH, 66450 Bexbach, www.kerndruck.deSign up for our free Markets
Germany magazine
www.gtai.com/markets-germany-subscribe

Picture Credits: Cover: ©GettyImges/Andrew Brookes; back:©GettyImges/typhoonski; portrait: ©GTAI/Illing & Vossbeck
Fotografie

Find out more about German industry
at our YouTube channel
www.youtube.com/user/gtai

Reproduction, in whole or in part, only permissible with expressprior authorization. All market data provided is based on the mostcurrent market information available at the time of publication.
Germany Trade & Invest accepts no liability for the actuality,accuracy, or completeness of the information provided.

Notes: All rights reserved ©Germany Trade & Invest, August 2022

Order Number: 20829/2